SE9904673D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE9904673D0
SE9904673D0 SE9904673A SE9904673A SE9904673D0 SE 9904673 D0 SE9904673 D0 SE 9904673D0 SE 9904673 A SE9904673 A SE 9904673A SE 9904673 A SE9904673 A SE 9904673A SE 9904673 D0 SE9904673 D0 SE 9904673D0
Authority
SE
Sweden
Prior art keywords
compounds
novel compounds
phenyl
thiophenyl
furanyl
Prior art date
Application number
SE9904673A
Other languages
English (en)
Swedish (sv)
Inventor
William Brown
Christopher Walpole
Original Assignee
Astra Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Inc filed Critical Astra Pharma Inc
Priority to SE9904673A priority Critical patent/SE9904673D0/xx
Publication of SE9904673D0 publication Critical patent/SE9904673D0/xx
Priority to TW089126669A priority patent/TWI238822B/zh
Priority to JP2001546378A priority patent/JP2003518022A/ja
Priority to PL00356797A priority patent/PL356797A1/xx
Priority to EEP200200334A priority patent/EE05035B1/xx
Priority to AU25643/01A priority patent/AU780714B2/en
Priority to EP00989096A priority patent/EP1242402B1/en
Priority to AT00989096T priority patent/ATE254120T1/de
Priority to UA2002064508A priority patent/UA72945C2/uk
Priority to SK885-2002A priority patent/SK285753B6/sk
Priority to NZ519985A priority patent/NZ519985A/en
Priority to ES00989096T priority patent/ES2210028T3/es
Priority to IL15012600A priority patent/IL150126A0/xx
Priority to RU2002114345/04A priority patent/RU2260006C2/ru
Priority to CNB008189765A priority patent/CN1225465C/zh
Priority to SI200030296T priority patent/SI1242402T1/xx
Priority to TR2004/00237T priority patent/TR200400237T4/xx
Priority to DE60006583T priority patent/DE60006583T2/de
Priority to MXPA02006062A priority patent/MXPA02006062A/es
Priority to US10/149,911 priority patent/US6784181B2/en
Priority to KR1020027007835A priority patent/KR100807515B1/ko
Priority to BR0016578-6A priority patent/BR0016578A/pt
Priority to HK03100181.6A priority patent/HK1048113B/en
Priority to DK00989096T priority patent/DK1242402T3/da
Priority to CZ20022122A priority patent/CZ20022122A3/cs
Priority to HU0300298A priority patent/HUP0300298A2/hu
Priority to PT00989096T priority patent/PT1242402E/pt
Priority to PCT/SE2000/002559 priority patent/WO2001045637A2/en
Priority to CA002393568A priority patent/CA2393568C/en
Priority to MYPI20005939A priority patent/MY125394A/en
Priority to CO00096314A priority patent/CO5271646A1/es
Priority to ARP000106799A priority patent/AR027039A1/es
Priority to ZA200204256A priority patent/ZA200204256B/en
Priority to IL150126A priority patent/IL150126A/en
Priority to BG106806A priority patent/BG65456B1/bg
Priority to IS6423A priority patent/IS2194B/is
Priority to NO20022918A priority patent/NO323402B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
SE9904673A 1999-12-20 1999-12-20 Novel compounds SE9904673D0 (sv)

Priority Applications (37)

Application Number Priority Date Filing Date Title
SE9904673A SE9904673D0 (sv) 1999-12-20 1999-12-20 Novel compounds
TW089126669A TWI238822B (en) 1999-12-20 2000-12-14 Benzamide compounds and pharmaceutical composition for use in the treatment of pain
CA002393568A CA2393568C (en) 1999-12-20 2000-12-15 Diarylmethylpiperazines
TR2004/00237T TR200400237T4 (tr) 1999-12-20 2000-12-15 Yeni karışımlar.
US10/149,911 US6784181B2 (en) 1999-12-20 2000-12-15 Piperazine-containing compounds useful in the treatment of pain
EEP200200334A EE05035B1 (et) 1999-12-20 2000-12-15 1-[fenüül-(8-kinolinüül)metüül]piperasiini derivaadid ning nende kasutamine meditsiinis
AU25643/01A AU780714B2 (en) 1999-12-20 2000-12-15 Novel compounds
EP00989096A EP1242402B1 (en) 1999-12-20 2000-12-15 Novel compounds
AT00989096T ATE254120T1 (de) 1999-12-20 2000-12-15 Neue verbindungen
UA2002064508A UA72945C2 (uk) 1999-12-20 2000-12-15 Сполука (варіанти), фармацевтична композиція, спосіб лікування (варіанти)
SK885-2002A SK285753B6 (sk) 1999-12-20 2000-12-15 Deriváty benzamidu, farmaceutické kompozície s ich obsahom a ich použitie
NZ519985A NZ519985A (en) 1999-12-20 2000-12-15 Opioid receptor ligands for treating pain and gastrointestinal disorders
ES00989096T ES2210028T3 (es) 1999-12-20 2000-12-15 Nuevos compuestos.
IL15012600A IL150126A0 (en) 1999-12-20 2000-12-15 Novel 4(piperazinyl(8-quinolinyl)methyl) benzamides
RU2002114345/04A RU2260006C2 (ru) 1999-12-20 2000-12-15 4-(пиперазинил(8-хинолинил)метил)бензамиды, фармацевтическая композиция и способ лечения боли
CNB008189765A CN1225465C (zh) 1999-12-20 2000-12-15 新化合物
SI200030296T SI1242402T1 (en) 1999-12-20 2000-12-15 Novel compounds
JP2001546378A JP2003518022A (ja) 1999-12-20 2000-12-15 新規な化合物
DE60006583T DE60006583T2 (de) 1999-12-20 2000-12-15 Neue verbindungen
MXPA02006062A MXPA02006062A (es) 1999-12-20 2000-12-15 Compuestos novedosos.
PL00356797A PL356797A1 (en) 1999-12-20 2000-12-15 Novel compounds
KR1020027007835A KR100807515B1 (ko) 1999-12-20 2000-12-15 신규 화합물
BR0016578-6A BR0016578A (pt) 1999-12-20 2000-12-15 Composto, uso do mesmo, composição farmacêutica, e, métodos para o tratamento de dor, para o tratamento de distúrbios gastrointestinais e para o tratamento de danos na coluna vertebral.
HK03100181.6A HK1048113B (en) 1999-12-20 2000-12-15 New compound
DK00989096T DK1242402T3 (da) 1999-12-20 2000-12-15 Nye forbindelser
CZ20022122A CZ20022122A3 (cs) 1999-12-20 2000-12-15 Nové sloučeniny
HU0300298A HUP0300298A2 (hu) 1999-12-20 2000-12-15 4-[Piperazinil-8-(kinolinil-metil)]benzamid-származékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
PT00989096T PT1242402E (pt) 1999-12-20 2000-12-15 Novos compostos
PCT/SE2000/002559 WO2001045637A2 (en) 1999-12-20 2000-12-15 Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides
MYPI20005939A MY125394A (en) 1999-12-20 2000-12-18 Novel compounds.
CO00096314A CO5271646A1 (es) 1999-12-20 2000-12-19 Compuestos novedosos
ARP000106799A AR027039A1 (es) 1999-12-20 2000-12-20 Compuestos novedosos
ZA200204256A ZA200204256B (en) 1999-12-20 2002-05-28 Novel compounds.
IL150126A IL150126A (en) 1999-12-20 2002-06-10 4- (Piperazinyl (8-Coinolinyl) methyl) benzamides, pharmaceutical preparations containing them and their use in the preparation of drugs for therapy
BG106806A BG65456B1 (bg) 1999-12-20 2002-06-10 Пиперазин хинолинметил бензамиди, фармацевтичен състав, който ги съдържа, и тяхното използване католекарствени средства
IS6423A IS2194B (is) 1999-12-20 2002-06-14 Efnasambönd sem innihalda píperasín sem eru gagnleg til meðhöndlunar á sársauka
NO20022918A NO323402B1 (no) 1999-12-20 2002-06-18 Nye forbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904673A SE9904673D0 (sv) 1999-12-20 1999-12-20 Novel compounds

Publications (1)

Publication Number Publication Date
SE9904673D0 true SE9904673D0 (sv) 1999-12-20

Family

ID=20418209

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904673A SE9904673D0 (sv) 1999-12-20 1999-12-20 Novel compounds

Country Status (34)

Country Link
US (1) US6784181B2 (enExample)
EP (1) EP1242402B1 (enExample)
JP (1) JP2003518022A (enExample)
KR (1) KR100807515B1 (enExample)
CN (1) CN1225465C (enExample)
AT (1) ATE254120T1 (enExample)
AU (1) AU780714B2 (enExample)
BG (1) BG65456B1 (enExample)
BR (1) BR0016578A (enExample)
CA (1) CA2393568C (enExample)
CO (1) CO5271646A1 (enExample)
CZ (1) CZ20022122A3 (enExample)
DE (1) DE60006583T2 (enExample)
DK (1) DK1242402T3 (enExample)
EE (1) EE05035B1 (enExample)
ES (1) ES2210028T3 (enExample)
HK (1) HK1048113B (enExample)
HU (1) HUP0300298A2 (enExample)
IL (2) IL150126A0 (enExample)
IS (1) IS2194B (enExample)
MX (1) MXPA02006062A (enExample)
MY (1) MY125394A (enExample)
NO (1) NO323402B1 (enExample)
NZ (1) NZ519985A (enExample)
PL (1) PL356797A1 (enExample)
PT (1) PT1242402E (enExample)
RU (1) RU2260006C2 (enExample)
SE (1) SE9904673D0 (enExample)
SK (1) SK285753B6 (enExample)
TR (1) TR200400237T4 (enExample)
TW (1) TWI238822B (enExample)
UA (1) UA72945C2 (enExample)
WO (1) WO2001045637A2 (enExample)
ZA (1) ZA200204256B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8987736B2 (en) * 2000-07-10 2015-03-24 Amit Goyal [100] or [110] aligned, semiconductor-based, large-area, flexible, electronic devices
SE0100764D0 (sv) 2001-03-07 2001-03-07 Astrazeneca Ab New assymetric process
EP1395567B1 (en) * 2001-05-18 2009-01-14 AstraZeneca AB 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
PL371297A1 (en) * 2001-10-29 2005-06-13 Ardent Pharmaceuticals, Inc. Method of treating depression with delta receptor agonist compounds
SE0203303D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0400027D0 (sv) * 2004-01-09 2004-01-09 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
HRP20120343T1 (hr) * 2004-08-02 2012-05-31 Astrazeneca Ab Derivati diarilmetil piperazina, njihovi pripravci i njihova uporaba
SE0401968D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
EP2024364A1 (en) * 2006-05-26 2009-02-18 Neuromed Pharmaceuticals, Ltd. Heterocyclic compounds as calcium channel blockers
MY148880A (en) * 2006-10-20 2013-06-14 Astrazeneca Ab N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression
JP2011520956A (ja) * 2008-05-20 2011-07-21 アストラゼネカ・アクチエボラーグ 不安大うつ病性障害を処置する方法
KR20200091883A (ko) * 2017-12-12 2020-07-31 갓코호우징 도쿄리카다이가쿠 활성 에너지선 경화형 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585209A5 (enExample) 1973-06-29 1977-02-28 Cermol Sa
DE2900810A1 (de) 1979-01-11 1980-07-24 Cassella Ag Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung
IT1140978B (it) 1980-05-23 1986-10-10 Selvi & C Spa 1-(4-clorobenzidril)-4-(2,3-diidros sipropil)-piperazina, metodi per la sua preparazione e relative composizione farmaceutiche
GB8320701D0 (en) 1983-08-01 1983-09-01 Wellcome Found Chemotherapeutic agent
IT1196150B (it) 1984-06-19 1988-11-10 Poli Ind Chimica Spa Derivati di 1-(bis-(4-fluorofenil)metil)-4-(3-fenil-2-propenil)-esaidro-1h-1,4-diazepina ad attivita' calcio antagonista,sua preparazione e composizioni che lo contengono
SE8500573D0 (sv) 1985-02-08 1985-02-08 Ferrosan Ab Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US5028610A (en) 1987-03-18 1991-07-02 Sankyo Company Limited N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
US4829065A (en) 1987-04-24 1989-05-09 Syntex Pharmaceuticals, Ltd. Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US4826844A (en) 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
DE69007471T2 (de) 1989-11-22 1994-06-23 Janssen Pharmaceutica N.V., Beerse Verfahren zur verhütung oder zur begrenzung einer reperfusionsschädigung.
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
US5574159A (en) 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
US5681830A (en) 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
US5807858A (en) 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
SE9201956D0 (sv) * 1992-06-25 1992-06-25 Kabi Pharmacia Ab Novel nicotinicacid esters
FR2696744B1 (fr) 1992-10-12 1994-12-30 Logeais Labor Jacques Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
ES2149881T3 (es) 1993-07-30 2000-11-16 Delta Pharmaceuticals Inc Compuestos de piperazina usados en terapia.
JP3352184B2 (ja) 1993-11-12 2002-12-03 株式会社アズウェル ピペラジン不飽和脂肪酸誘導体
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
TW548271B (en) 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE9604786D0 (sv) * 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
DK1049676T3 (da) 1997-12-24 2006-01-16 Ortho Mcneil Pharm Inc 4-[Aryl(piperidin-4-yl)]aminobenzamider, som binder til delta-opioidreceptoren

Also Published As

Publication number Publication date
NO323402B1 (no) 2007-04-23
WO2001045637A3 (en) 2001-12-13
CA2393568C (en) 2009-08-18
RU2260006C2 (ru) 2005-09-10
EP1242402B1 (en) 2003-11-12
KR100807515B1 (ko) 2008-02-26
BG106806A (bg) 2003-03-31
IL150126A0 (en) 2002-12-01
DE60006583T2 (de) 2004-09-30
EP1242402A2 (en) 2002-09-25
PL356797A1 (en) 2004-07-12
TR200400237T4 (tr) 2004-04-21
EE200200334A (et) 2003-10-15
DE60006583D1 (de) 2003-12-18
EE05035B1 (et) 2008-06-16
CN1434816A (zh) 2003-08-06
HK1048113B (en) 2004-04-30
WO2001045637A2 (en) 2001-06-28
AU2564301A (en) 2001-07-03
CN1225465C (zh) 2005-11-02
IL150126A (en) 2008-06-05
NZ519985A (en) 2004-05-28
BG65456B1 (bg) 2008-08-29
CO5271646A1 (es) 2003-04-30
SK285753B6 (sk) 2007-07-06
KR20020067919A (ko) 2002-08-24
BR0016578A (pt) 2002-09-24
MXPA02006062A (es) 2002-12-05
SK8852002A3 (en) 2003-05-02
ZA200204256B (en) 2003-08-28
JP2003518022A (ja) 2003-06-03
ATE254120T1 (de) 2003-11-15
NO20022918L (no) 2002-08-02
UA72945C2 (uk) 2005-05-16
RU2002114345A (ru) 2004-01-10
PT1242402E (pt) 2004-03-31
MY125394A (en) 2006-07-31
CA2393568A1 (en) 2001-06-28
ES2210028T3 (es) 2004-07-01
IS6423A (is) 2002-06-14
TWI238822B (en) 2005-09-01
HUP0300298A2 (hu) 2003-06-28
US20030119845A1 (en) 2003-06-26
AU780714B2 (en) 2005-04-14
DK1242402T3 (da) 2004-03-01
CZ20022122A3 (cs) 2002-11-13
IS2194B (is) 2007-01-15
US6784181B2 (en) 2004-08-31
NO20022918D0 (no) 2002-06-18
HK1048113A1 (en) 2003-03-21

Similar Documents

Publication Publication Date Title
SE0001207D0 (sv) Novel compounds
MXPA03010445A (es) Derivados de 4(fenil-piperazinil-metil) benzamida y su uso para tratamiento del dolor, ansiedad o trastornos gastrointestinales.
SE9904673D0 (sv) Novel compounds
SE0103313D0 (sv) Novel compounds
MXPA03010439A (es) Derivados de 4-(fenil-piperidin-a-iliden-metil)-benzamida y su uso para tratar dolor, ansiedad o trastornos gastrointestinales.
SE0001208D0 (sv) Novel compounds
BG106807A (en) Novel compounds
SE0001209D0 (sv) Novel compounds
SE0101766D0 (sv) Novel compounds
SE0101768D0 (sv) Novel compounds
SE0101767D0 (sv) Novel compounds
SE0101769D0 (sv) Novel compounds
SE0101771D0 (sv) Novel compounds
SE0101770D0 (sv) Novel compounds
SE0101773D0 (sv) Novel compounds
SE0101772D0 (sv) Novel compounds
AR027040A1 (es) Compuestos novedosos